On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma
- PMID: 12707735
- DOI: 10.1007/s00277-003-0622-4
On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma
Comment on
-
Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.J Natl Cancer Inst. 2002 Jun 19;94(12):883-93. doi: 10.1093/jnci/94.12.883. J Natl Cancer Inst. 2002. PMID: 12072542 Review. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical